Apimeds Pharmaceuticals

Matawan, United States

Apimeds Pharmaceuticals is a company that develops therapeutic application solutions for honeybee venom used for inflammatory conditions.

$100.0M raised

Dec 2025

Post-IPO Equity

Biotechnology Health Care Pharmaceutical

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Apimeds Pharmaceuticals

How much funding has Apimeds Pharmaceuticals raised?

Apimeds Pharmaceuticals has raised $100.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2025.

Where is Apimeds Pharmaceuticals headquartered?

Apimeds Pharmaceuticals is headquartered in Matawan, United States.

What does Apimeds Pharmaceuticals do?

Apimeds Pharmaceuticals is a company that develops therapeutic application solutions for honeybee venom used for inflammatory conditions.

What stage is Apimeds Pharmaceuticals at?

Apimeds Pharmaceuticals is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 1, 2025.

MLA

"Apimeds Pharmaceuticals — Funding & Investors." VCBacked, December 1, 2025, https://www.vcbacked.co/company/apimeds-pharmaceuticals. Accessed July 1, 2026.

APA

VCBacked. (2025). Apimeds Pharmaceuticals — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/apimeds-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=Apimeds Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/apimeds-pharmaceuticals |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 1, 2025.